Structural Biology of Human H3K9 Methyltransferases
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
UNLABELLED: SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Phylogenetic tree of human histone methyltransferases. Phylogeny is based on a multiple sequence alignment of the methyltransferase domain including the N-SET, Pre_SET, SET, I-SET, and Post-SET motifs. Substrate selectivity was extracted from Kouzarides [1]. Enzymes with solved structure are highlighted by a frame, dotted if no peptide substrate complex is available. Structures solved in the present work are framed in red.](https://figures.cochat.ai/paper-figures/f223740273dd4504943d435b9d71af7c/structural-biology-of-human-h3k9-methyltransferases-figure-1.jpg)

![Figure 3 Structural determinants of G9a mono/di-methylation specificity. A model of substrate lysine-bound G9a (Top panel) was generated from the superposition of the active sites of the GPL ternary complex and GLP. Y1067 of G9a stabilizes the di-methylamine end of the substrate lysine in an orientation where the lone-pair is not facing the co-factor, thereby disfavoring transfer of a third methyl group. The Y1067F mutant loses this restriction and can tri-methylate its substrate, as indicated in the table. Previous work had shown that the F1152Y G9a mutant can only mono-methylate H3K9 [29].](https://figures.cochat.ai/paper-figures/ecf8fd2d2aa84552bf80a968a979ba0d/structural-biology-of-human-h3k9-methyltransferases-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“Graphics program COOT [36] was used for model building and PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8570 T a b le 1 .”
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903 · cited 1×
“. Tri-methylation of lysine 9 of histone 3 (H3K9) mediates chromatin recruitment of HP1, heterochromatin condensation and gene silencing”
BackgroundMethylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057 · cited 2×
“Methylation of histone tails is one of the fundamental events of epigenetic signaling [3].”
BackgroundSubstructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodPartitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,152 · cited 1×
“The specificity of PRDM2 is unknown [25].”
Heterochromatin and Epigenetic Control of Gene Expression
Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · cited 1×
“Post-translational modifications of histone proteins regulate chromatin compaction, mediate epigenetic regulation of transcription, and control cellular differentiation in health and disease [1,2].”
BackgroundThe SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 978 · cited 1×
“HKMTs catalyze the transfer of a methyl group from the co-factor S-adenosyl-Lmethionine (SAM) to a substrate lysine and, with the exception of DOT1L, are all organized around a canonical SET domain [7,8].”
Background
Cited by
Items 101–200 of 274
Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression
Pezone, A., Taddei, M. L., Tramontano, A., Dolcini, J., Boffo, F. L., Rosa, M. D., Parri, M., Stinziani, S., Comito, G., Porcellini, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa599 · Cited by 47
“Histone H3 methylation changes induced by TGF-(cid:2) 1 at the SNAI1 and WIF1 promoters are produced by the recruitment of demethy-lases and methyltransferases (43,44).”
SUV39 SET domains mediate crosstalk of heterochromatic histone marks
Stirpe, A., Guidotti, N., Northall, S. J., Kilic, S., Hainard, A., Vadas, O., Fierz, B., & Schalch, T. (2021) · eLife · doi:10.7554/elife.62682 · Cited by 45
Sundriyal, S., Malmquist, N. A., Caron, J., Blundell, S. A., Liu, F., Chen, X., Srimongkolpithak, N., Jin, J. J., Charman, S. A., Scherf, A., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402098 · Cited by 45
Rahman, Z., Bazaz, M. R., Devabattula, G., Khan, M. A., & Godugu, C. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22674 · Cited by 45
Evolution ofPrdmGenes in Animals: Insights from Comparative Genomics
Vervoort, M., Meulemeester, D., Béhague, J., & Kerner, P. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv260 · Cited by 47
“The PR domain corresponds to a subtype of a SET domain, which is found in many histone lysine methyltransferases (HMTs) (Huang 2002; Wu et al. 2010).”
BackgroundFeng, J., & Meng, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.946811 · Cited by 43
“H3K9 methylation, in particular H3K9me2 and H3K9me3, is usually related to heterochromatin formation and gene suppression (Bannister et al., 2001).”
BackgroundInfluentialJagannathan, V., Bannoehr, J., Plattet, P., Hauswirth, R., Drögemüller, C., Drögemüller, M., Wiener, D. J., Doherr, M. G., Owczarek‐Lipska, M., Galichet, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003848 · Cited by 39
“The crystal structure of SUV39H2 has been solved and the catalytically active site for the methyltransferase activity is located within the so-called SET domain [21].”
BackgroundPR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase
Blazer, L. L., Lima‐Fernandes, E., Gibson, E., Eram, M. S., Loppnau, P., Arrowsmith, C. H., Schapira, M., & Vedadi, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721472 · Cited by 43
“tyrosine of SET domain PMTs is believed to contribute in the stabilization of the substrate binding site (38).”
BackgroundSelf-citationZang, L., Kondengaden, S. M., Zhang, Q., Li, X., Sigalapalli, D. K., Kondengadan, S. M., Huang, K., Li, K. K., Li, S., Xiao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18730 · Cited by 38
“While histone acetylation regulated by HDAC and their corresponding writer enzymes HATs, protein methylation is similarly regulated by protein lysine methyltransferases enzymes (PKMT), protein arginine methyltransferases (PRMT) and their corresponding demethylase enzymes [1, 28].”
BackgroundIshimoto, K., Kawamata, N., Uchihara, Y., Okubo, M., Fujimoto, R., Gotoh, E., Kakinouchi, K., Mizohata, E., Hino, N., Okada, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165766 · Cited by 42
Insights for the Design of Protein Lysine Methyltransferase G9a Inhibitors
Mariasoosai, C., Dhayalan, A., Hsieh, H., & Coumar, M. S. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0396 · Cited by 36
Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities
Shah, K., & Rawal, R. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200103111539 · Cited by 39
Opposing Chromatin Signals Direct and Regulate the Activity of Lysine Demethylase 4C (KDM4C)
Pack, L. R., Yamamoto, K. R., & Fujimori, D. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.696864 · Cited by 42
“Indeed, several H3K9 methyltransferases are partially inhibited by H3K4me3 (16, 17), and MLL2, a H3K4 methyltransferase, is similarly inhibited by H3K9me3 (18).”
BackgroundHuman SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome
Tellier, M., & Chalmers, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky937 · Cited by 34
Wang, M. Y., Liow, P., Guzman, M. I. T., & Qi, J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00062 · Cited by 35
Koh, X., Joy, J. K., Poulsen, A., Li, R., Tan, Y. T. F., Shim, Y., Min, J., Wu, L., Ngo, A., Peng, J., et al. (2014) · Biochemical Journal · doi:10.1042/bj20140374 · Cited by 38
“Some members of the PRDM family show strong context dependency and bidirectional transcriptional activity, e.g. PRDM2 action in response to oestrogen levels, and PRDM16 function during brown fat specification (7,32,33).”
InfluentialSelf-citationMossman, D., & Scott, R. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023127 · Cited by 33
“For instance, trimethylation of histone H3 lysine 4 (H3K4me3) is an active mark [7] whilst methylation of H3K9 and H3K27 appears at transcriptionally silent gene promoters [7,8].”
Blancafort, P., Jin, J. J., & Frye, S. V. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080697 · Cited by 41
“For example, the lysine methyltransferase G9a, which deposits H3K9me2 and H3K9me1 in euchromatin (Wu et al., 2010), interacts with DNA methyltransferases through ankyrin domains (Feldman et al., 2006).”
BackgroundInfluentialOpen Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery
Lee, W. H. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002164 · Cited by 35
“With funding from the Wellcome Trust and the Ontario government, and medicinal chemistry expertise from industrial partners, the project was launched and focused on underexplored protein families such as lysine demethylases (KDMs; [15–19]), histone methyltransferases (HMTs; [20–24]), and Bromodomains [25–27] (full lis…”
Structural biology-based insights into combinatorial readout and crosstalk among epigenetic marks
Du, J., & Patel, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.011 · Cited by 32
“Similarly, the H3K9me3 methyltransferases G9a and GLP (G9a Like Protein) have SET domains for deposition of the H3K9me mark, which in turn use their ankyrin repeat domains to specifically recognize the H3K9me mark [68,69], suggesting a self-reinforcing feedback loop mechanism.”
BackgroundThe making of a Barr body: the mosaic of factors that eXIST on the mammalian inactive X chromosome
Dixon-McDougall, T., & Brown, C. J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0016 · Cited by 40
“Of the eight different enzymes which methylate H3K9 in a context-dependent fashion (Shinkai 2007) the dimethylase activity of G9a and GLP (EHMT2/1) is particularly important for XCI (Figure 3A) (Wu et al. 2010).”
BackgroundLysine Possesses the Optimal Chain Length for Histone Lysine Methyltransferase Catalysis
Temimi, A. H. K. A., Reddy, Y. V., White, P. B., Guo, H., Qian, P., & Mecinović, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-16128-4 · Cited by 32
The nucleophilic amino group of lysine is central for histone lysine methyltransferase catalysis
Temimi, A. H. K. A., Amatdjais‐Groenen, H. I. V., Reddy, Y. V., Blaauw, R. H., Guo, H., Qian, P., & Mecinović, J. (2019) · Communications Chemistry · doi:10.1038/s42004-019-0210-8 · Cited by 31
Morishita, M., & di Luccio, E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.061 · Cited by 33
“A similar conserved double hydrogen-bond is observed in the structures of H4K20-SETD8, H3K4-SETD7 and H3K27-vSET [26].”
BackgroundInfluentialA High Throughput Scintillation Proximity Imaging Assay for Protein Methyltransferases
Ibáñez, G., Shum, D., Blum, G., Bhinder, B., Radu, C., Antczak, C., Luo, M., & Djaballah, H. (2012) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620712800194468 · Cited by 32
Shields, K. M., Tooley, J. G., Petkowski, J. J., Wilkey, D. W., Garbett, N. C., Merchant, M. L., Cheng, A., & Tooley, C. E. S. (2017) · Protein Science · doi:10.1002/pro.3202 · Cited by 29
“to both these methyltransferases when mutated to phenylalanine or alanine.(22,23) The corresponding aro-”
BackgroundInhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II)
Lenstra, D. C., Temimi, A. H. K. A., & Mecinović, J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.02.043 · Cited by 31
Chen, D., Cheng, D., Dong, G., Srinivasan, K., Min, J., Noinaj, N., & Huang, R. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00770 · Cited by 28
Self-citationCypris, O., Eipel, M., Franzen, J., Rösseler, C., Tharmapalan, V., Kuo, C., Vieri, M., Nikolić, M., Kirschner, M., Brümmendorf, T. H., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00914-5 · Cited by 28
Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1
Zhang, R., Li, X., Liang, Z. T., Zhu, K., Lu, J., Kong, X., Ouyang, S., Li, L., Zheng, Y. G., & Luo, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072424 · Cited by 27
“1 [39] suggested during our MD simulation, unlike in GLP (PDB code: 3HNA) [40], there are no water molecules in the active site forming steady hydrogen bond with substrate guanidino, which indicated that water molecules are not directly involved in reaction (Figure S3).”
Piao, L., Nakakido, M., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2016) · Oncotarget · doi:10.18632/oncotarget.8072 · Cited by 28
“The automethylated lysine 392 located within the post-SET domain; recent studies suggest that post-SET domain is relatively flexible or disordered without the cofactor SAM or peptide binding [15, 18, 28].”
The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation
Teferi, W. M., Desaulniers, M., Noyce, R. S., Shenouda, M. M., Umer, B. A., & Evans, D. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173056 · Cited by 29
Structural basis for product specificities of MLL family methyltransferases
Li, Y., Zhao, L., Zhang, Y., Wu, P., Xu, Y. M., Mencius, J., Zheng, Y., Wang, X., Xu, W., Huang, N., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.08.022 · Cited by 26
Subpocket Analysis Method for Fragment-Based Drug Discovery
Kalliokoski, T., Olsson, T. S. G., & Vulpetti, A. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300523r · Cited by 26
Horowitz, S. A., Adhikari, U., Dirk, L. M. A., Rizzo, P. A. D., Mehl, R. A., Houtz, R. L., Al‐Hashimi, H. M., Scheiner, S., & Trievel, R. C. (2014) · ACS Chemical Biology · doi:10.1021/cb5001185 · Cited by 26
Forezi, L. D. S. M., Tolentino, N. M. D. C., de Souza, A. M. T., Castro, H. C., Montenegro, R. C., Dantas, R. F., de Oliveira, M. D. C. F., Silva, F. P., Barreto, L., Burbano, R. M. R., et al. (2014) · Molecules · doi:10.3390/molecules19056651 · Cited by 26
Yao, J., Chu, Y., An, R., & Guo, H. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200364m · Cited by 31
Consequences of assisted reproductive techniques on the embryonic epigenome in cattle
Rivera, R. M. (2019) · Reproduction Fertility and Development · doi:10.1071/rd19276 · Cited by 33
“SETDB2 is a member of the SUV39 family of heterochromatinpromoting lysine methyltransferases, which also includes SUV39H1, SUV39H2 and G9a (Wu et al. 2010), pointing to the need for an intact and undisturbed epigenome during the preimplantation stage for proper gene expression and timing of…”
BackgroundG9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications
Ni, Y., Shi, M., Liu, L., Lin, D., Zeng, H., Ong, C. J., & Wang, Y. Z. (2024) · Cancers · doi:10.3390/cancers16122175 · Cited by 26
“Wu et al. reported the indispensability of the tyrosine residue Y1067 for the catalytic function of G9a as an HMT [21].”
BackgroundSelf-citationRots, D., Bouman, A., Yamada, A., Levy, M. A., Dingemans, A. J. M., Vries, B. B. A. D., Ruiterkamp‐Versteeg, M., de Leeuw, N., Ockeloen, C. W., Pfundt, R., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.06.008 · Cited by 31
Balan, S., Iwayama, Y., Ohnishi, T., Fukuda, M., Shirai, A., Yamada, A., Weirich, S., Schuhmacher, M. K., Dileep, K. V., Endo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01199-7 · Cited by 27
Sanchez, N. A., Kallweit, L. M., Trnka, M. J., Clemmer, C. L., & Al‐Sady, B. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101276 · Cited by 25
Graham, S. E., Tweedy, S. E., & Carlson, H. A. (2016) · Protein Science · doi:10.1002/pro.2912 · Cited by 26
Edge and face withdrawal strength of large screws in particleboard and medium density fiberboard
Rajak, Z. I. B. H. A., & Eckelman, C. A. (1993) · Forest Products Journal · Cited by 24
SAH derived potent and selective EZH2 inhibitors
Kung, P., Huang, B., Zehnder, L. R., Tatlock, J. H., Bingham, P., Krivacic, C. T., Gajiwala, K. S., Diehl, W. C., Yu, X., & Maegley, K. A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.017 · Cited by 23
Genetically Encoded Molecular Biosensors To Image Histone Methylation in Living Animals
Sekar, T. V., Foygel, K., Gelovani, J. G., & Paulmurugan, R. (2014) · Analytical Chemistry · doi:10.1021/ac502629r · Cited by 23
TALE-directed local modulation of H3K9 methylation shapes exon recognition
Bieberstein, N. I., Kozáková, E., Huranová, M., Thakur, P. K., Krchňáková, Z., Krausová, M., Oesterreich, F. C., & Staněk, D. (2016) · Scientific Reports · doi:10.1038/srep29961 · Cited by 25
Zheng, S., Wang, J., Feng, Y., Wang, J., & Ye, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045437 · Cited by 21
“Structures of SUV39 family HKMTs show that the pre-SET domain coordinates three zinc ions with nine invariant Cys residues [42–44].”
BackgroundChu, Y., Yao, J., & Guo, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037674 · Cited by 21
“For GLP there is a Tyr residue (Y1124) hydrogen-bonding to the methyl accepting nitrogen in the X-ray structures of GLP complexed with the substrate, H3K9me and H3K9me2 peptides [15]; the equivalent residue in G9a is Y1067.”
BackgroundResultInfluentialEnzyme-Dependent Lysine Deprotonation in EZH2 Catalysis
Kipp, D. R., Quinn, C. M., & Fortin, P. D. (2013) · Biochemistry · doi:10.1021/bi400805w · Cited by 27
Huang, H., Li, H., Zhao, T., Khan, A. A., Pan, R., Wang, S., Wang, S., & Liu, X. (2022) · Journal of Cancer · doi:10.7150/jca.66404 · Cited by 20
“G9a participates in diverse biological processes, including DNA replication and DNA damage and repair, and catalyzes methylation processes such as methylation of p53, DNMT1, HDAC1 and KLF12 [21-24].”
BackgroundEssential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia
Zhang, Y., Owens, K. M., Hatem, L., Glass, C., Karuppaiah, K., Camargo, F. D., & Perkins, A. S. (2013) · Blood · doi:10.1182/blood-2012-08-453662 · Cited by 26
Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization
Rabal, O., Castellar, A., & Oyarzábal, J. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0288-5 · Cited by 18
Haws, S. A., Miller, L. J., Luz, D. R. L., Kuznetsov, V. I., Trievel, R. C., Crăciun, G., & Denu, J. M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104938 · Cited by 19
“PRDM3 and PRDM16 lack the penultimate tyrosine residue of the consensus ELxF/YDY SET domain sequence, which has both structural and catalytic importance in canonical SET domain-containing HMTs (19, 45, 48, 49).”
BackgroundSchnee, P., Pleiss, J., & Jeltsch, A. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2318547 · Cited by 20
“…as more than one position can function in this way. the dimethyltransferase G9a could be turned into a trimethyltransferase by the Y1067F mutation (wu et al. 2010), but into a monomethyltransferase by F1152Y indicating that two susceptible positions exist (collins et al. 2005). likewise, the…”
BackgroundMethodInfluentialTan, S., Hu, R., Tan, Y.-L., Liu, J., & Liu, W. (2014) · Tumor Biology · doi:10.1007/s13277-013-1593-2 · Cited by 17
“PRDMs are a group of nuclear proteins belonging to the family of histone methyltransferases [6].”
BackgroundAskew, E. B., Bai, S., Parris, A. B., Minges, J. T., & Wilson, E. M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.028 · Cited by 17
“Human SUV39H2 has a preformed docking platform for the histone 3 tail similar to other histone H3 lysine 9 methyltransferases (Wu et al., 2010).”
BackgroundRolando, M., Chung, I. Y. W., Xu, C., Gómez-Valero, L., England, P., Cygler, M., & Buchrieser, C. (2023) · mBio · doi:10.1128/mbio.01655-23 · Cited by 19
“The SET domain is similar to other human histone methyltransferases, such as GLP/EHMT1, G9a/EHMT2, PRDM2, and SUV39H2 (24), and is composed of four segments (16): the pre-SET segment (84–114aa), the core SET domain (115–147aa and 190–234aa), insertion I-SET segment (148–189aa), and post-SET segment…”
BackgroundAllsopp, T. E., Bunnage, M. E., & Fish, P. V. (2010) · MedChemComm · doi:10.1039/c0md00055h · Cited by 19
Chen, J., Lin, X. J., Park, K.-J., Lee, K. R., & Park, H. (2018) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0156-4 · Cited by 16
Papatsirou, M., Diamantopoulos, M. A., Katsaraki, K., Kletsas, D., Kontos, C. K., & Scorilas, A. (2022) · Genes · doi:10.3390/genes13071133 · Cited by 15
“The human PRMT1 is highly conserved in eukaryotes and has three functional domains in its canonical structure [5].”
BackgroundBiochemical validation of EHMT1 missense mutations in Kleefstra syndrome
Yamada, A., Shimura, C., & Shinkai, Y. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0413-3 · Cited by 20
Hwang, Y. J., Hyeon, S. J., Kim, Y., Lim, S., Lee, M. Y., Kim, J., Londhe, A. M., Gotina, L., Kim, Y., Pae, A. N., et al. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1900160 · Cited by 18
Targets of histone H3 lysine 9 methyltransferases
Levinsky, A. J., McEdwards, G., Sethna, N. S., & Currie, M. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1026406 · Cited by 18
“with the majority of trimethylation coming from SUV39H1 and SUV39H2 in vivo (Wu et al., 2010; Montavon et al., 2021) (Figure 3).”
BackgroundPark, I., Hwang, Y. J., Kim, T., Viswanath, A. N. I., Londhe, A. M., Jung, S. Y., Sim, K. M., Min, S., Lee, J. E., Seong, J., et al. (2017) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-017-0052-3 · Cited by 16
Mariasoosai, C., Hsieh, H., & Coumar, M. S. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1491422 · Cited by 14
“SETDB1 and SETDB2 give rise to mono-methyl lysine (Schultz, Ayyanathan, Negorev, Maul, & Rauscher, 2002); G9a and GLP to mono-, and di-methyl lysine; and SUV39 forms di- and tri-methyl lysine from a pre mono-methylated lysine substrate (Wu et al., 2010).”
BackgroundSETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer
Prashanth, S., Maniswami, R. R., Rajajeyabalachandran, G., & Jegatheesan, S. K. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103982 · Cited by 14
Satish, M., Nivya, M. A., Abhishek, S., Nakarakanti, N. K., Shivani, D., Vani, M. V., & Rajakumara, E. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25399 · Cited by 16
“H3K9 methyltransferases GLP, G9a, SUVH39H1, SUVH39H2, SUVH4, and SUVH9 were taken as templates to analyze SUVH proteins.(33,34) MLL1, MLL3, SET1A, and SET1B were used as templates to analyze ATX class H3K4 methyltransferases.”
Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors
Chen, D., Meng, Y., Yu, D., Noinaj, N., Cheng, X., & Huang, R. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00279 · Cited by 13
B., L. Q. I., Bartsch, N., Kouzel, I. U., Busengdal, H., Richards, G. S., Steinmetz, P. R. H., & Rentzsch, F. (2023) · Nature Communications · doi:10.1038/s41467-023-39789-4 · Cited by 15
Du, Y., Sun, M., Li, Z., Wu, X., Qu, Q., Ai, H., & Liu, L. (2025) · Science Advances · doi:10.1126/sciadv.adu1864 · Cited by 12
“Compared with the substrate-binding structure of Clr4 homologs like DIM5 in Neurospora crassa ( 46 ), G9a ( 47 ), and GLP1 ( 48 ) in H sapiens , the conformation of H3 residues 7 to 13 in our structure is similar, and the SI region adopts a concerted recognition behavior when it is tightly…”
Clifton, M. K., Westman, B. J., Thong, S. Y., O’Connell, M. R., Webster, M. W., Shepherd, N. E., Quinlan, K. G. R., Crossley, M., Blobel, G. A., & Mackay, J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106011 · Cited by 14
“Structures have also been determined for the PR domains of PRDM1, 2, 4, 9, 10, 11 and 12 (although only structures of PRDM2 have been published [37,38]).”
BackgroundInvestigation of in vitro histone H3 glycosylation using H3 tail peptides
Merx, J., Hintzen, J. C. J., Proietti, G., Elferink, H., Wang, Y., Porzberg, M. R. B., Sondag, D., Bilgin, N., Park, J., Mecinović, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21883-0 · Cited by 12
Brown, L. J., Baranowski, M., Wang, Y., Schrey, A. K., Lenz, T., Taverna, S. D., Cole, P. A., & Sefkow, M. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.08.013 · Cited by 13
“The protein was purified as described previously [19] and stored at −80 °C until use.”
MethodEpigenetic Regulation of Chromatin in Prostate Cancer
Natesan, R., Aras, S., Effron, S. S., & Asangani, I. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_17 · Cited by 13
Roy, A., Niharika, N., Chakraborty, S., Mishra, J., Singh, S. P., & Patra, S. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.011 · Cited by 13
The function of histone methyltransferase SETDB1 and its roles in liver cancer
Zhang, E., & He, P. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1500263 · Cited by 11
Current and Emerging Approaches Targeting G9a for the Treatment of Various Diseases
He, H., Li, X., Su, F., Jin, H. Y., Zhang, J., & Wang, Y. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02781 · Cited by 12
Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential
McGlynn, K. A., Sun, R., Vonica, A., Rudzinskas, S. A., Zhang, Y., & Perkins, A. S. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.04.010 · Cited by 13
Crystal structure of Legionella pneumophila type IV secretion system effector LegAS4
Son, J., Jo, C. H., Murugan, R. N., Bang, J. K., Hwang, K. Y., & Lee, W. C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.094 · Cited by 11
Kim, S. Y., Hwang, S., Choi, M. K., Park, S., Nam, K.-Y., & Kim, I. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109277 · Cited by 12
The structure of the cysteine-rich region from human histone-lysine N-methyltransferase EHMT2 (G9a)
Kerchner, K. M., Mou, T., Sun, Y., Rusnac, D.-V., Sprang, S. R., & Briknarová, K. (2021) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2021.100050 · Cited by 12
“, 2018), and (C) the SET domain with the pre-SET and post-SET regions (orange; PDB ID 3HNA and 5JIN) (Jayaram et al., 2016; Wu et al., 2010).”
BackgroundInfluentialStudies on substrate specificity of Jmjd2a-c histone demethylases
Ponnaluri, V. K. C., Vavilala, D. T., & Mukherji, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.073 · Cited by 11
“This result correlates well with the crystallographic data [19], which identified interactions between the guanidino group of 1 Arg and the carboxyl groups of Asp1145, Asp1135, Asp1131 of G9a-like-protein (G9a-likeprotein and G9a share >80% identity in their SET domain).”
ResultBon, C., Halby, L., & Arimondo, P. B. (2020) · Epigenomics · doi:10.2217/epi-2020-0203 · Cited by 11
Head–tail carboboration of multisubstituted alkenes enabled by chain recognition
Kong, W., Wu, D., Hong, W., Gao, B., Li, P., Li, Y., Li, Y., & Yin, G. (2025) · Nature Chemistry · doi:10.1038/s41557-025-01903-y · Cited by 10
Iyamu, I. D., Zhao, T., & Huang, R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00632 · Cited by 10
The Role of Histone Methylation and Methyltransferases in Gene Regulation
Cui, J. Y., Fu, Z. D., & Dempsey, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812433-8.00002-2 · Cited by 17
Structure–Activity Relationship Studies of Venglustat on NTMT1 Inhibition
Deng, Y., Dong, G., Meng, Y., Noinaj, N., & Huang, R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01854 · Cited by 10
Davidovich, C., & Zhang, Q. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200238 · Cited by 9
Sécula, A., Bluy, L. E., Chapuis, H., Bonnet, A., Collin, A., Gress, L., Cornuez, A., Martin, X., Bodin, L., Bonnefont, C. M. D., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-09066-7 · Cited by 11
“were also downregulated in the ducklings from the Met-restricted dams; DNMT3A involved in DNA methylation, and EZH2 and PRDM2 which are both SAMdependent histone methyltransferases [45] involved in chromatin remodeling regulating gene expression [46].”
BackgroundExploration of the Activation Mechanism of the Epigenetic Regulator MLL3: A QM/MM Study
Miranda‐Rojas, S., Blanco-Esperguez, K., Tuñón, I., Kästner, J., & Mendizábal, F. (2021) · Biomolecules · doi:10.3390/biom11071051 · Cited by 8
“However, based on the increasing crystallographic evidence, particularly from the protein lysine methyltransferase (PKMT) of Rubisco pointed out that the suggested tyrosine was incapable of deprotonating the Lys-ε-NH3, alternatively suggesting a mechanism based on deprotonation by bulk solvent [15].”
BackgroundKhella, M. S., Schnee, P., Weirich, S., Bui, T., Bröhm, A., Bashtrykov, P., Pleiss, J., & Jeltsch, A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104796 · Cited by 8
“Moreover, the G9a residue Y1067, corresponding to NSD2 Y1092, has been shown to control the dimethylation product specificity of G9a, and its mutation to phenylalanine converted G9a to a trimethyltransferase (73).”
BackgroundHajar, M., Werner, T., Gajić, M., Stark, H., & Sadek, B. S. (2025) · Medicinal Research Reviews · doi:10.1002/med.22119 · Cited by 9
“Y1067 in the catalytic centre of G9a determines whether mono ‐ , di ‐ or, after an increased incubation period, trimethylation takes place [51, 52].”
Swalm, B. M., Hallenbeck, K. K., Majer, C. R., Jin, L., Scott, M. P., Moyer, M. P., Copeland, R. A., & Wigle, T. J. (2013) · Biochemical Journal · doi:10.1042/bj20130439 · Cited by 7
Dynamic changes of histone methylation in male germ cells during spermatogenesis
Bilmez, Y., & Öztürk, S. (2023) · F&S Reviews · doi:10.1016/j.xfnr.2023.07.001 · Cited by 9
SETDB1: Progress and prospects in cancer treatment potential and inhibitor research
Ma, T., Xu, F., Hou, Y., Shu, Y., Zhao, Z., Zhang, Y., Bai, L., Lu, F., & Zhong, L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107219 · Cited by 8
SETDB1 as a cancer target: challenges and perspectives in drug design
Hassanie, H., Penteado, A. B., de Almeida, L. C., Calil, R. L., Emery, F. D. S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00366c · Cited by 7
Fine-tuning of lysine side chain modulates the activity of histone lysine methyltransferases
Temimi, A. H. K. A., Merx, J., van Noortwijk, C. J., Proietti, G., Buijs, R., White, P. B., Rutjes, F. P. J. T., Boltje, T. J., & Mecinović, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-78331-0 · Cited by 7
Hsu, C., Chang, K., Chuang, B. T.-M., Chu, M., Lin, P.-W., Liu, H., Kao, S., Liu, Y., Huang, C.-T., Wang, M., et al. (2023) · Cancers · doi:10.3390/cancers15164150 · Cited by 6
Polverino, A., Longo, A., Donizetti, A., Drongitis, D., Frucci, M., Schiavo, L., Carotenuto, G., Nicolais, L., Piscopo, M., Vitale, E., et al. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2516-x · Cited by 7
“H3K9 dimethylation is found in silent regions of heterochromatin, while H3K4 dimethylation is specific for transcriptionally active euchromatic regions (Noma et al. 2001; Ruthenburg et al. 2007; Wu et al. 2010; Mosch et al. 2011; Bannister et al. 2001).”
Background
Metadata
- Authors
- Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., Plotnikov, A. N., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Plotnikov, Alexander N.
- Schapira, Matthieu
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-11
- Volume
- 5
- Issue
- 1
- Pages
- e8570
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2797608
- OpenAlex
- W2106473601
- Cited by
- 268
- References
- 39
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 11 · 2023: 14 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 17 · 2012: 21
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Ontario Innovation Trust
- Genome Canada (1097737)
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- H3K9 methyltransferase, SET domain, G9a, GLP, SUV39H2, PRDM2, histone methylation, epigenetic regulation, S-adenosylmethionine, induced fit, electrostatic interactions, protein structure
- MeSH terms
- Histone Methyltransferases, Crystallization, Humans, Models, Molecular, Protein Conformation, Histone-Lysine N-Methyltransferase, Substrate Specificity, Catalytic Domain, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.